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In this issue, Remmelink and colleagues present very inter-
esting data on the function of the coronary microcirculation
after PCI-treated ST-segment elevation myocardial infarc-
tion (STEMI) [1].
The virtues of direct mechanical coronary revascularisation
after acute thrombotic occlusion are well documented. Mor-
tality after acute myocardial infarction has steeply declined
over the past decades and is now well below 10 % [2]. This is
at least in part attributable to instant restoration of epicardial
flow by stent placement, which puts primary PCI on a rela-
tively short list of medical interventions that are directly life-
saving and also preserve quality of life.
As cardiologists we regularly witness such benefits of
primary PCI. As an example, an amateur tennis player was
brought into our cathlab recently with a large anterior myo-
cardial infarction. He was haemodynamically unstable and
in severe distress. After a quick and successful PCI proce-
dure, he recovered fully and actually asked the medical staff
whether he could return back to the court that same day
because he was on the brink of winning his game (which
was naturally denied…). Such exemplary stories have led
some of us to believe that there is not much left to gain in the
initial treatment strategy of AMI.
But the truth is of course a little different. Despite the
approximate 95 % angiographic success rate (TIMI-3 flow),
the majority of patients will be left with scarred myocardi-
um, exposing them to increased risk to develop heart failure.
Especially the patients who show microvascular obstruction
(MVO) at cardiac magnetic resonance (CMR) are prone to
proceed to left ventricular dysfunction and its associated
complications [3]. The exact pathophysiological substrate
of this CMR-defined phenomenon remains unclear but it is
associated with reduced or absent myocardial tissue perfu-
sion and therefore sometimes also referred to as ‘no reflow’.
This notion has opened a new potential therapeutic win-
dow since if we could identify the patients that are at risk
early, we could also think of early adjunctive therapies after
primary PCI.
In this light, studies as performed by Remmelink are of
great importance.
The availability of intracoronary pressure and flow wires
enables the quantification of microvascular function at dif-
ferent time points. Using such techniques, this group previ-
ously showed a direct relation between left ventricular
recovery and coronary flow velocity reserve, as measured
either directly or in the first week after AMI [4, 5]. Conduc-
tance catheters can give insights into LV performance under
different haemodynamic conditions. This has been
employed especially in the pre-clinical setting, and provided
us with very important insights on the autoregulatory way
the heart responds to increased load as described in the
Frank-Starling law.
Combining the two above-mentioned techniques, the au-
thors show in their present study that patients with an
impaired left ventricular arterial coupling, as determined
by the ratio of ventricular end-systolic elastance to effective
arterial elastance, display a decreased coronary flow veloc-
ity reserve. Interestingly, this was not related to a decreased
maximal flow velocity rate during hyperaemia, which could
be postulated after a large myocardial infarction and subse-
quent loss of microcirculatory capacity. Rather, it was relat-
ed to an increased flow velocity rate at baseline. Resting
flow is governed by vasomotor autoregulation and tightly
matched to oxidative metabolism, which in turn is related to
its main determinants such as end-systolic wall stress, con-
tractility, and heart rate [6]. It is of interest to note that the
patient group with a more pronounced compromised cardiac
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function also displayed a markedly higher heart rate. The
increased coronary flow at rest may therefore reflect higher
demand dictated by the haemodynamic status. Alternatively,
impaired myocardial energetics and reduced cardiac effi-
ciency could also have induced the apparent mismatch be-
tween resting perfusion and cardiac work [7].
Another aspect that we should keep in mind is the fact that
the Doppler flow wire does not measure absolute flow but
rather flow velocity. Thus, potentially it is only an increase in
flow velocity that was observed, for example due to a different
capacity of the vascular bed. To further differentiate between
the potential mechanisms it would therefore be of interest to
measure absolute myocardial perfusion in ml/min/g with tech-
niques such as PET and MRI [8].
Using such quantitative perfusion imaging techniques in
combination with invasive pressure measurements, Marques
et al. studied coronary microvascular resistance in patients
with a varying degree of LV dysfunction in the setting of a
chronic myocardial infarction [9]. In that study, solely fo-
cusing on the residual viable tissue adjacent to scar rather
than the complete infarct-related vascular territory, resting
microvascular resistance was found to be increased. In
contrast, minimal microvascular resistance was not
compromised, similar to the findings of Remmelink et
al. In the future, the further integration of invasive and
non-invasive techniques to measure myocardial flow and
microvascular resistance will probably give us more in-
sights on the pathophysiological substrate of left ven-
tricular dysfunction after successful primary PCI.
The authors are to be lauded for their very elaborate study,
incorporating several physiological parameters that are only
seldom measured in the clinical setting, which is dominated
by large-scale pharmaco-interventional studies, focussing at
hard endpoints. Such large-scale studies are of great impor-
tance to decide whether or not new therapies and interventions
are to be implemented in daily clinical practice and they form
the basis for evidence-based and guideline-directed medicine.
The offspring of true innovation, however, most often lies in
small-scale studies and the study by Remmelink is a nice
example.
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